Lord, Abbett & Co’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.3M | Sell |
995,425
-336,276
| -25% | -$13.6M | 0.13% | 185 |
|
|
2025
Q1 | $68.4M | Buy |
1,331,701
+51,714
| +4% | +$2.66M | 0.24% | 114 |
|
|
2024
Q4 | $70.9M | Buy |
1,279,987
+685,111
| +115% | +$37.9M | 0.22% | 122 |
|
|
2024
Q3 | $19.6M | Buy |
594,876
+131,636
| +28% | +$4.33M | 0.06% | 333 |
|
|
2024
Q2 | $12.6M | Buy |
463,240
+381,014
| +463% | +$10.4M | 0.04% | 369 |
|
|
2024
Q1 | $2.99M | Buy |
+82,226
| New | +$2.99M | 0.01% | 510 |
|